Authors: OLVER I DAVY M WEBSTER L EGORIN M LUFTNER D PARK SH

Citation: I. Olver et al., A PHASE-I TRIAL WITH PHARMACOKINETICS OF PACLITAXEL AND ALTRETAMINE FOR OVARIAN-CANCER RELAPSING FOLLOWING CISPLATIN, Annals of oncology, 9, 1998, pp. 327-327

Authors: CHARNICK SB FRACASSO P EGORIN M SONNEVELD P BLEEHAN N GIACCONE G NIEDERBERGER W SMITH HT PEARCE T SIKIC BI

Citation: Sb. Charnick et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF SDZ PSC-833, A NOVEL MULTIDRUG-RESISTANCE REVERSING AGENT, IN PHASE-1 TRIALS WITH CHEMOTHERAPEUTIC-AGENTS, European journal of cancer, 33, 1997, pp. 775-775

Authors: SEIDMAN AD TIERSTEN A HUDIS C GOLLUB M BARRETT S YAO TJ LEPORE J GILEWSKI T CURRIE V CROWN J HAKES T BASELGA J SKLARIN N MOYNIHAN ME TONG W EGORIN M KEARNS C SPRIGGS D NORTON L

Citation: Ad. Seidman et al., PHASE-II TRIAL OF PACLITAXEL BY 3-HOUR INFUSION AS INITIAL AND SALVAGE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2575-2581

Authors: EISENBERGER MA REYNO L SINIBALDI V SRIDHARA R CARDUCCI M EGORIN M

Citation: Ma. Eisenberger et al., THE EXPERIENCE WITH SURAMIN IN ADVANCED PROSTATE-CANCER, Cancer, 75(7), 1995, pp. 1927-1934

Authors: LESLIE J KUJAWA JM EDDINGTON N EGORIN M EISEMAN J

Citation: J. Leslie et al., STABILITY PROBLEMS WITH TAXOL IN MOUSE PLASMA DURING ANALYSIS BY LIQUID-CHROMATOGRAPHY, Journal of pharmaceutical and biomedical analysis, 11(11-12), 1993, pp. 1349-1352